• Bone Health
  • Immunology
  • Hematology
  • Respiratory
  • Dermatology
  • Diabetes
  • Gastroenterology
  • Neurology
  • Oncology
  • Ophthalmology
  • Rare Disease
  • Rheumatology

The Top 5 Biosimilar Articles for the Week of December 6

Video

Here are the top 5 biosimilar articles for the week of December 6, 2021.

Hi, I’m Skylar Jeremias for The Center for Biosimilars®, your resource for clinical, regulatory, business, and policy news in the rapidly changing world of biosimilars.

Here are the top 5 biosimilar articles for the week of December 6, 2021.

Number 5: The arrival of biosimilars for filgrastim and pegfiltrastim coincided with higher use of granulocyte colony-stimulating factor (G-CSF) for prophylaxis against febrile neutropenia, but many high-risk patients still do not receive the treatment.

Number 4: In the second setback this year for etanercept biosimilars, the US District Court for the District of New Jersey ordered Samsung Bioepis to delay marketing Eticovo until 2029.

Number 3: Henlius gained approval in China for a bevacizumab biosimilar (Hanbeitai) and officials discussed combination therapy options with experimental therapy serplulimab and ophthalmology treatment.

Number 2: In a review, Sandoz researchers discussed lingering barriers that prevent insulin prices from falling to more affordable levels.

Number 1: Researchers reported findings that suggest a different reimbursement system for Medicare Part B biologics could lead to significantly more robust savings.


To read all of these articles and more, visit centerforbiosimilars.com.

Recent Videos
Josh Canavan, PharmD, head of pharmacy at RazorMetrics
Here are the top 5 biosimilar articles for the week of January 27, 2025.
Here are the top 5 biosimilar articles for the week of January 20, 2025.
Here are the top 5 biosimilar articles for the week of January 13, 2025.
Sarah Hudson-DiSalle, PharmD, RPh, FACCC
Tiago Biachi, MD, PhD
Here are the top 5 biosimilar articles for the week of December 30, 2024.
Here are the top 5 biosimilar articles for the week of December 16, 2024.
Elie Bahou, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.